The first Flexion Therapeutics trade was made in Q1 2017.
Since then Chuck Royce bought shares seven more times and sold shares on six occasions. The investor completely sold their stake between Q4 2020 and Q3 2021.
Avg closing price
Price range
Sold -451 Thousand shares
Q3 2021
Avg closing price
$6.23
Price range
$4.40
-
$8.20
Sold 19.1% shares (-106 Thousand shares)
Q2 2021
Avg closing price
$8.50
Price range
$6.99
-
$9.67
Sold 11.2% shares (-70.1 Thousand shares)
Q1 2021
Avg closing price
$11.46
Price range
$8.40
-
$13.09
Sold 10.5% shares (-74 Thousand shares)
Q4 2020
Avg closing price
$11.62
Price range
$10.13
-
$13.43
Increased shares by 5.1% (+34 Thousand shares)
Q3 2020
Avg closing price
$12.25
Price range
$10.40
-
$13.85
Increased shares by 15.8% (+91 Thousand shares)
Q2 2020
Avg closing price
$10.37
Price range
$6.65
-
$13.15
Increased shares by 68.9% (+235 Thousand shares)
Q1 2020
Avg closing price
$15.06
Price range
$5.53
-
$21.13
Increased shares by 5.0% (+16.3 Thousand shares)
Q4 2019
Avg closing price
$16.86
Price range
$12.88
-
$20.95
Increased shares by 204.8% (+218 Thousand shares)
Q3 2019
Avg closing price
$11.87
Price range
$9.07
-
$15.49
Increased shares by 609.7% (+91.6 Thousand shares)
Q2 2019